RxDoctor Payments Data
★ My doctorsLook up a doctor →

Guy Culpepper

Family Medicine · Dallas, TXNPI 1407849052

Payments from drug & device makers

$3,299in general payments, 2019–2025

Across 181 payments — averaging $18.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$179
  • Pfizer$172
  • AstraZeneca$154
  • Merck$150
  • Stryker$149
  • plus $1K from 31 others

What the payments were for

  • Food & beverage$3,27299%
  • Other$271%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)62$1,221
Lilly USA, LLC9$179
Pfizer10$172
AstraZeneca11$154
Merck13$150
Stryker1$149
Amgen(2 entities)9$140
GSK8$111
Corium, LLC4$101
Gilead6$86
Kowa Pharmaceuticals America, Inc.4$66
Teva Pharmaceuticals USA, Inc.3$58
Amarin Pharma, Inc.4$57
Boehringer Ingelheim3$53
Dexcom, Inc.3$51
Takeda Pharmaceuticals U.S.A., Inc.3$45
Romark Laboratories, LC2$41
Bausch Health US, LLC2$40
Genentech USA, Inc.2$38
Idorsia Pharmaceuticals US Inc2$38
Medtronic2$36
Boston Scientific1$35
IBSA Pharma Inc.2$29
Baxter Healthcare1$27
Daiichi Sankyo Inc.2$23
Abbott1$22
Jazz Pharmaceuticals Inc.1$21
Neos Therapeutics, LP1$20
Novartis1$18
Novo Nordisk1$18
Sanofi Pasteur Inc.1$16
Azurity Pharmaceuticals, Inc.1$16
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$15
Antares Pharma, Inc.1$14
Phathom Pharmaceuticals, Inc.1$14
Astellas Pharma US Inc1$13
Ironshore Pharmaceuticals Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,299 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas →

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide33$34,138
JardianceEmpagliflozin15$25,943
EliquisApixaban23$19,705
MounjaroTirzepatide14$15,959
Celecoxib21$3,211
Dutasteride38$2,182
SynthroidLevothyroxine Sodium21$2,081
Donepezil Hcl26$2,035
Rosuvastatin Calcium95$1,411
Atorvastatin Calcium186$1,276
Metoprolol Succinate53$1,028
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide22$886
Nebivolol Hcl11$753
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide27$739
Tamsulosin Hcl41$612

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$18$34,13833 claims
Boehringer IngelheimJardiance$53$25,94315 claims
PfizerEliquis$172$19,70523 claims
Lilly USA, LLCMounjaro$179$15,95914 claims
AbbVieSynthroid$1,221$2,08121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →